Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-06

Clinical Trial Update: Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Painless Sharp Wound Debridement gel (Lidocaine-23% / Tetra-caine-7%) to EMLA 5% cream for leg ulcers and ecthyma; status and results no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EMLA 5% Cream (lidocaine-prilocaine cream)
  • Lidocaine-23% / Tetra-caine-7% Gel

Snippet

Sponsor: Juerg Hafner | Conditions: Ulcus Cruris, Ecthyma | Phase 2 | Status: UNKNOWN